Genetic underpinnings explored: OPA1 deletion and complex phenotypes on chromosome 3q29

DOI: https://doi.org/10.1186/s12920-024-01850-6

2024-04-20

BMC Medical Genomics

Abstract:Copy number variations (CNVs) have emerged as significant contributors to the elusive genetic causality of inherited eye diseases. In this study, we describe a case with optic atrophy and a brain aneurysm, in which a de novo CNV 3q29 deletion was identified.

genetics & heredity

What problem does this paper attempt to address?

A Novel OPA1 Mutation in a Chinese Family with Autosomal Dominant Optic Atrophy

Juanjuan Zhang,Yimin Yuan,Bing Lin,Hao Feng,Yan Li,Xianning Dai,Huihui Zhou,Xujie Dong,Xiao-Ling Liu,Min-Xin Guan

DOI: https://doi.org/10.1016/j.bbrc.2012.02.073

IF: 3.1

2012-01-01

Biochemical and Biophysical Research Communications

Abstract:A large four-generation Chinese family with autosomal dominant optic atrophy (ADOA) was investigated in the present study. Eight of the family members were affected in this pedigree. The affected family members exhibited early-onset and progressive visual impairment, resulting in mild to profound loss of visual acuity. The average age-at-onset was 15.9years. A new heterozygous mutation c.C1198G was identified by sequence analysis of the 12th exon of the OPA1 gene. This mutation resulted in a proline to alanine substitution at codon 400, which was located in an evolutionarily conserved region. This missense mutation in the GTPase domain was supposed to result in a loss of function for the encoded protein and act through a dominant negative effect. No other mutations associated with optic atrophy were found in our present study. The c.C1198G heterozygous mutation in the OPA1 gene may be a novel key pathogenic mutation in this pedigree with ADOA. Furthermore, additional nuclear modifier genes, environmental factors, and psychological factors may also contribute to the phenotypic variability of ADOA in this pedigree.
Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.

Brett M Reid,Jennifer B Permuth,Y Ann Chen,Brooke L Fridley,Edwin S Iversen,Zhihua Chen,Heather Jim,Robert A Vierkant,Julie M Cunningham,Jill S Barnholtz-Sloan,Steven Narod,Harvey Risch,Joellen M Schildkraut,Ellen L Goode,Alvaro N Monteiro,Thomas A Sellers

DOI: https://doi.org/10.1158/1055-9965.EPI-18-0833

2019-01-01

Cancer Epidemiology Biomarkers & Prevention

Abstract:BACKGROUND:Germline DNA copy number variation (CNV) is a ubiquitous source of genetic variation and remains largely unexplored in association with epithelial ovarian cancer (EOC) risk. METHODS:CNV was quantified in the DNA of approximately 3,500 cases and controls genotyped with the Illumina 610k and HumanOmni2.5M arrays. We performed a genome-wide association study of common (>1%) CNV regions (CNVRs) with EOC and high-grade serous (HGSOC) risk and, using The Cancer Genome Atlas (TCGA), performed in silico analyses of tumor-gene expression. RESULTS:Three CNVRs were associated (P < 0.01) with EOC risk: two large (∼100 kb) regions within the 610k set and one small (<5 kb) region with the higher resolution 2.5M data. Large CNVRs included a duplication at LILRA6 (OR = 2.57; P = 0.001) and a deletion at CYP2A7 (OR = 1.90; P = 0.007) that were strongly associated with HGSOC risk (OR = 3.02; P = 8.98 × 10-5). Somatic CYP2A7 alterations correlated with EGLN2 expression in tumors (P = 2.94 × 10-47). An intronic ERBB4/HER4 deletion was associated with reduced EOC risk (OR = 0.33; P = 9.5 × 10-2), and somatic deletions correlated with ERBB4 downregulation (P = 7.05 × 10-5). Five CNVRs were associated with HGSOC, including two reduced-risk deletions: one at 1p36.33 (OR = 0.28; P = 0.001) that correlated with lower CDKIIA expression in TCGA tumors (P = 2.7 × 10-7), and another at 8p21.2 (OR = 0.52; P = 0.002) that was present somatically where it correlated with lower GNRH1 expression (P = 5.9 × 10-5). CONCLUSIONS:Though CNV appears to not contribute largely to EOC susceptibility, a number of low-to-common frequency variants may influence the risk of EOC and tumor-gene expression. IMPACT:Further research on CNV and EOC susceptibility is warranted, particularly with CNVs estimated from high-density arrays.
Novel heterozygous OPA3 variant in a family with congenital cataracts, sensorineural hearing loss and neuropathy, without optic atrophy and comparison of pathogenic and population variants

Monica Penon‐Portmann,Kendyl Naugle,Frank Brodie,Julie Schallhorn,Paul Griggs,Joyce So

DOI: https://doi.org/10.1002/ajmg.a.63846

2024-08-23

American Journal of Medical Genetics Part A

Abstract:Heterozygous mutations in the OPA3 gene are associated with autosomal dominant optic atrophy‐3 (OPA3), whereas biallelic mutations cause autosomal recessive 3‐methylglutaconic aciduria type III. To date, all cases with pathogenic variants in the gene OPA3 have presented with optic atrophy. We report a large family with congenital cataracts, hearing loss and neuropathy, with a likely pathogenic novel missense variant in OPA3, c.30G>C; p.(Lys10Asn) that segregates with disease in the family pedigree. The family's clinical presentation has significant phenotypic overlap with previously reported cases of OPA3, except for a notable lack of optic atrophy. The analysis of all known disease‐associated variants in OPA3 revealed an enrichment in missense variants in patients with OPA3 phenotype compared with loss‐of‐function variants, which are more likely to be observed in individuals with 3‐methylglutaconic aciduria type III, supporting different mechanisms of disease. This case broadens the clinical and genetic spectrum associated with OPA3 mutations and highlights that optic atrophy is not an obligate feature of OPA3‐related disorders.

genetics & heredity
A Large Family with Inherited Optic Disc Anomalies: a Correlation Between a New Genetic Locus and Complex Ocular Phenotypes

Decai Wang,Xinyuan Pan,Jiangdong Ji,Shun Gu,Xiantao Sun,Chao Jiang,Weiyi Xia,Zhihua Qiu,Xiaoli Kang,Sijia Ding,Qinghuai Liu,Xue Chen,Fang Lu,Chen Zhao

DOI: https://doi.org/10.1038/s41598-017-07730-7

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Congenital cavitary optic disc anomalies (CODA) is clinically typified by an enlarged excavation of optic disc in diverse degrees. Here, we report the clinical and genetic findings in a four-generation Chinese family with a complicated form of autosomal dominant CODA. Cardinal manifestations included bilateral excavated optic disc with multiple cilioretinal vessels emerging and bilateral retinoschisis with great variability in the range of extension and severity. Other intra-familial phenotypic diversities were also noted, including severity in retinal atrophy, onset age of visual impairment and presence of congenital nystagmus and strabismus. Genome-wide linkage analysis and fine mapping mapped a novel locus for CODA to a 34.3 cM interval between D14S972 and D14S139 at 14q12-q22.1. A maximum multi-point log odds score of 3.901 was reached at D14S275. However, no mutation was identified by exome sequencing or direct sequencing of PAX6 and PAX2 genes, suggesting that the mutation may reside within a regulatory element. In conclusion, we find retinoschisis as a necessary consequence of optic nerve head (ONH) anomalies. The complicated phenotype observed in the family provided additional insights into the inherited ONH anomalies. Mapping of a novel locus, 14q12-q22.1, implies a new disease-causing gene and potential distinct pathogenesis for CODA.
Looks Can Be Deceiving: Diagnostic Power of Exome Sequencing in Debunking 15q11.2 Copy Number Variations

Meossi,Carrer,Ciaccio,Pezzoli,Pezzani,Silipigni,Sciacca,Tenconi,Esposito,De Laurentiis,Pantaleoni,Marchisio,Natacci,D'Arrigo,Iascone,Milani

DOI: https://doi.org/10.3390/genes15111441

IF: 4.141

2024-11-08

Genes

Abstract:Background/Objectives: the pathogenetic role of 15q11.2 Copy Number Variations (CNVs) remains contentious in the scientific community, as microdeletions and microduplications in this region are linked to neurodevelopmental disorders with variable expressivity. This study aims to explore the diagnostic utility of Exome Sequencing (ES) in a cohort of pediatric patients with 15q11.2 CNVs. Methods: We enrolled 35 probands with 15q11.2 microdeletions or microduplications from two genetic centers between January 2021 and January 2023. Chromosomal Microarray Analysis (CMA) and ES were performed with written consent obtained from all parents. Pathogenic variants were classified according to ACMG guidelines. Results: CMA identified additional pathogenic CNVs in 3 of 35 children (9%). Subsequent ES revealed likely pathogenic or pathogenic variants in 11 of 32 children (34%). Notably, a higher percentage of isolated autism spectrum disorder (ASD) diagnoses was observed in patients without other CNVs or point mutations (p = 0.019). Conclusions: The ES analysis provided a diagnostic yield of 34% in this pediatric cohort with 15q11.2 CNVs. While the study does not dismiss the contribution of the CNV to the clinical phenotype, the findings suggest that ES may uncover the underlying causes of neurodevelopmental disorders. Continuous monitoring and further genetic testing are recommended for all 15q11.2 CNV carriers to optimize clinical management and familial counseling".

genetics & heredity
Increasing the Yield in Targeted Next-Generation Sequencing by Implicating CNV Analysis, Non-Coding Exons and the Overall Variant Load: The Example of Retinal Dystrophies

Tobias Eisenberger,Christine Neuhaus,Arif O. Khan,Christian Decker,Markus N. Preising,Christoph Friedburg,Anika Bieg,Martin Gliem,Peter Charbel Issa,Frank G. Holz,Shahid M. Baig,Yorck Hellenbroich,Alberto Galvez,Konrad Platzer,Bernd Wollnik,Nadja Laddach,Saeed Reza Ghaffari,Maryam Rafati,Elke Botzenhart,Sigrid Tinschert,Doris Börger,Axel Bohring,Julia Schreml,Stefani Körtge-Jung,Chayim Schell-Apacik,Khadijah Bakur,Jumana Y. Al-Aama,Teresa Neuhann,Peter Herkenrath,Gudrun Nürnberg,Peter Nürnberg,John S. Davis,Andreas Gal,Carsten Bergmann,Birgit Lorenz,Hanno J. Bolz

DOI: https://doi.org/10.1371/journal.pone.0078496

IF: 3.7

2013-11-12

PLoS ONE

Abstract:Retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA) are major causes of blindness. They result from mutations in many genes which has long hampered comprehensive genetic analysis. Recently, targeted next-generation sequencing (NGS) has proven useful to overcome this limitation. To uncover "hidden mutations" such as copy number variations (CNVs) and mutations in non-coding regions, we extended the use of NGS data by quantitative readout for the exons of 55 RP and LCA genes in 126 patients, and by including non-coding 5' exons. We detected several causative CNVs which were key to the diagnosis in hitherto unsolved constellations, e.g. hemizygous point mutations in consanguineous families, and CNVs complemented apparently monoallelic recessive alleles. Mutations of non-coding exon 1 of EYS revealed its contribution to disease. In view of the high carrier frequency for retinal disease gene mutations in the general population, we considered the overall variant load in each patient to assess if a mutation was causative or reflected accidental carriership in patients with mutations in several genes or with single recessive alleles. For example, truncating mutations in RP1, a gene implicated in both recessive and dominant RP, were causative in biallelic constellations, unrelated to disease when heterozygous on a biallelic mutation background of another gene, or even non-pathogenic if close to the C-terminus. Patients with mutations in several loci were common, but without evidence for di- or oligogenic inheritance. Although the number of targeted genes was low compared to previous studies, the mutation detection rate was highest (70%) which likely results from completeness and depth of coverage, and quantitative data analysis. CNV analysis should routinely be applied in targeted NGS, and mutations in non-coding exons give reason to systematically include 5'-UTRs in disease gene or exome panels. Consideration of all variants is indispensable because even truncating mutations may be misleading.

multidisciplinary sciences
Extremely rare CNVs contributing to Alzheimer disease risk: a case-control association analysis of exome sequencing data from 22,319 individuals

Olivier Quenez,Catherine Schramm,Kevin Cassinari,Aude Nicolas,Joan Groeneveld,Guillaume Huguet,Benjamin Grenier-Boley,Marc Hulsman,Anne-Claire Richard,Stéphane Rousseau,Shahzad Ahmad,Najaf Amin,Philippe Amouyel,Olivia Belbin,Céline Bellenguez,Claudine Berr,Anne Boland,Paola Bossù,Femke Bouwman,Jose Bras,Jordi Clarimon,Antonio Daniele,Jean-François Dartigues,Stéphanie Debette,Jean-François Deleuze,Nicola Denning,Oriol Dols-Icardo,Cornelia M, van Dujin,Victoria Fernandez,Wiesje M. van der Flier,Juan Fortea,Nick C. Fox,Ruth Frikke-Schmidt,Daniela Galimberti,Emmanuelle Genin,Roberta Ghidoni,Vilmantas Giedraitis,Johan J. P. Gille,Detelina Grozeva,Rita Guerreiro,Edna Grünblatt,John Hardy,Steffi G. Riedel-Heller,Mikko Hiltunen,Clive Holmes,Henne Holstege,Jakub Hort,Holger Hummerich,M. Arfan Ikram,M. Kamran Ikram,Martin Ingelsson,Iris E. Jansen,Amit Kawalia,Robert Kraaij,Patrick G. Kehoe,Marc Lathrop,Morgane Lacour,Afina W. Lemstra,Alberto Lleò,Lauren Luckcuck,Marcel M. A. M. Mannens,Rachel Marshall,Carlo Masullo,Simon Mead,Patrizia Mecocci,Alexandre de Mendonça,Alun Meggy,Shima Mehrabian,Merel O. Mol,Kevin Morgan,Alexandre Morin,Benedetta Nacmias,Penny J. Norsworthy,Florence Pasquier,Pau Pastor,Fabrizio Piras,Julius Popp,Alfredo Ramirez,Rachel Raybould,Richard Redon,Marcel J. T. Reinders,Fernando Rivadeneira,Jeroen G. J. van Rooij,Natalie S. Ryan,Salha Saad,Pascual Sanchez-Juan,Nikolaos Scarmeas,Philip Scheltens,Jonathan M. Schott,Davide Seripa,Daoud Sie,Rebecca Sims,Erik A. Sistermans,Sandro Sorbi,Kristel Sleegers,Resie van Spaendonk,John C. van Swieten,Niccolo Tesi,Betty M Tijms,André G. Uitterlinden,Magda Tsolaki,Pieter Jelle Visser,Michael Wagner,Julie Williams,Aline Zarea,EADB Consortium,David Wallon,Sébastien Jacquemont,Jean-Charles Lambert,Sven J. van der Lee,Camille Charbonnier,Gaël Nicolas

DOI: https://doi.org/10.1101/2024.10.28.24314051

2024-11-01

Abstract:Rare coding single nucleotide variants (SNV) and short insertions or deletions (indels) contribute to Alzheimer disease (AD) genetic risk, from pathogenic variants in autosomal dominant genes to risk factors with diverse effects. In contrast, copy number variants (CNV) have been scarcely studied, with the exception of a few autosomal dominant examples, such as APP gene duplications. We took advantage from a large case-control dataset of 22,319 exomes (4,150 early-onset AD (EOAD, onset ≤65 years), 8,519 late onset AD (LOAD) and 9,650 controls) to detect CNVs. We first identified 17 causative CNVs in autosomal dominant genes (9 novel: 7 APP and 2 MAPT duplications). After exclusion of carriers of these, we performed an original two-step analysis: (i) a protein-coding genome-wide analysis at the transcript level using a gene dosage strategy (EOAD versus controls) and then (ii) an integrated loss-of-function (LOF) analysis gathering short truncating variants with CNV-deletions in genes prioritized in (i) and in a list of known AD risk genes. We identified AD association with dosage of 20 genes at 4 different loci with a false discovery rate (FDR) below 10%, including the chr22q11.21 central region (FDR=0.0386), a region in linkage disequilibrium with the APOE locus on chr19 (FDR=0.0271), and two single-gene loci, namely FADS6 (FDR=0.0271), and ADI1 (FDR=0.0916). Replication in an independent dataset made of genotyping array data from 2,780 EOAD cases, 15,222 LOAD cases and 273,979 controls was consistent with the results obtained in the discovery dataset. The integrated LOF analysis helped narrowing the region of interest to the SCARF2-KLHL22-MED15 region at the 22q11.21 locus. In addition, the integrated LOF analysis highlighted rare deletions in the known AD-risk genes ABCA1 and ABCA7 that represented 10% (3/30) and 8.6% (10/115) of LOF alleles of these genes, respectively, as well as 4 TYROBP deletions. Finally, we identify CTSB LOF alleles as candidate rare AD risk factors (p=0.0089). In conclusion, our results show that carriers of a deletion of FADS6 or a 22q11.21 deletion encompassing the SCARF2-KLHL22-MED15 region, including patients with DiGeorge syndrome, may have a higher risk of developing AD. CNVs represent a source of genomic variation that can contribute to AD etiology in new genes but also in GWAS defined-genes.

Genetic and Genomic Medicine
Structural Variant Disrupting the Expression of the Remote FOXC1 Gene in a Patient with Syndromic Complex Microphthalmia

Julie Plaisancié,Bertrand Chesneau,Lucas Fares-Taie,Jean-Michel Rozet,Jacmine Pechmeja,Julien Noero,Véronique Gaston,Isabelle Bailleul-Forestier,Patrick Calvas,Nicolas Chassaing

DOI: https://doi.org/10.3390/ijms25052669

IF: 5.6

2024-02-26

International Journal of Molecular Sciences

Abstract:Ocular malformations (OMs) arise from early defects during embryonic eye development. Despite the identification of over 100 genes linked to this heterogeneous group of disorders, the genetic cause remains unknown for half of the individuals following Whole-Exome Sequencing. Diagnosis procedures are further hampered by the difficulty of studying samples from clinically relevant tissue, which is one of the main obstacles in OMs. Whole-Genome Sequencing (WGS) to screen for non-coding regions and structural variants may unveil new diagnoses for OM individuals. In this study, we report a patient exhibiting a syndromic OM with a de novo 3.15 Mb inversion in the 6p25 region identified by WGS. This balanced structural variant was located 100 kb away from the FOXC1 gene, previously associated with ocular defects in the literature. We hypothesized that the inversion disrupts the topologically associating domain of FOXC1 and impairs the expression of the gene. Using a new type of samples to study transcripts, we were able to show that the patient presented monoallelic expression of FOXC1 in conjunctival cells, consistent with the abolition of the expression of the inverted allele. This report underscores the importance of investigating structural variants, even in non-coding regions, in individuals affected by ocular malformations.

biochemistry & molecular biology,chemistry, multidisciplinary
A custom capture sequence approach for oculocutaneous albinism identifies structural variant alleles at the OCA2 locus

Stacie K. Loftus,Linnea Lundh,Dawn E. Watkins‐Chow,Laura L. Baxter,Erola Pairo‐Castineira,NISC Comparative Sequencing Program,Ian J. Jackson,William S. Oetting,William J. Pavan,David R. Adams

DOI: https://doi.org/10.1002/humu.24257

2021-08-01

Human Mutation

Abstract:Oculocutaneous albinism (OCA) is a heritable disorder of pigment production that manifests as hypopigmentation and altered eye development. Exon sequencing of known OCA genes is unsuccessful in producing a complete molecular diagnosis for a significant number of affected individuals. We sequenced the DNA of individuals with OCA using short-read custom capture sequencing that targeted coding, intronic and non-coding regulatory regions of known OCA genes and GWAS-associated pigmentation loci. We identified an OCA2 complex structural variant (CxSV), defined by a 143kb inverted segment reintroduced in intron 1, upstream of the native location. The corresponding CxSV junctions were observed in 11/390 probands screened. The 143kb CxSV presents in one family as a copy number variant (CNV) duplication for the 143kb region. In the remaining 10/11 families, the 143kb CxSV acquired an additional 184kb deletion across the same region, restoring exons 3-19 of OCA2 to a copy-number neutral state. Allele-associated haplotype analysis found rare SNVs rs374519281 and rs139696407 are linked with the 143kb CxSV in both OCA2 alleles. For individuals in which customary molecular evaluation does not reveal a biallelic OCA diagnosis, we recommend preliminary screening for these haplotype-associated rare variants, followed by junction-specific validation for the OCA2 143kb CxSV.This article is protected by copyright. All rights reserved.

genetics & heredity
The copy number variant architecture of psychopathology and cognitive development in the ABCD study

Zhiqiang Sha,Kevin Y. Sun,Benjamin Jung,Ran Barzilay,Tyler M. Moore,Laura Almasy,Jennifer K. Forsyth,Smrithi Prem,Michael J. Gandal,Jakob Seidlitz,Joseph T. Glessner,Aaron F. Alexander-Bloch

DOI: https://doi.org/10.1101/2024.05.14.24307376

2024-05-15

Abstract:Importance: Childhood is a crucial developmental phase for mental health and cognitive function, both of which are commonly affected in patients with psychiatric disorders. This neurodevelopmental trajectory is shaped by a complex interplay of genetic and environmental factors. While common genetic variants account for a large proportion of inherited genetic risk, rare genetic variations, particularly copy number variants (CNVs), play a significant role in the genetic architecture of neurodevelopmental disorders. Despite their importance, the relevance of CNVs to child psychopathology and cognitive function in the general population remains underexplored. Objective: Investigating CNV associations with dimensions of child psychopathology and cognitive functions. Design, Setting, and Participants: ABCD study focuses on a cohort of over 11,875 youth aged 9 to 10, recruited from 21 sites in the US, aiming to investigate the role of various factors, including brain, environment, and genetic factors, in the etiology of mental and physical health from middle childhood through early adulthood. Data analysis occurred from April 2023 to April 2024. Main Outcomes and Measures: In this study, we utilized PennCNV and QuantiSNP algorithms to identify duplications and deletions larger than 50Kb across a cohort of 11,088 individuals from the Adolescent Brain Cognitive Development study. CNVs meeting quality control standards were subjected to a genome-wide association scan to identify regions associated with quantitative measures of broad psychiatric symptom domains and cognitive outcomes. Additionally, a CNV risk score, reflecting the aggregated burden of genetic intolerance to inactivation and dosage sensitivity, was calculated to assess its impact on variability in overall and dimensional child psychiatric and cognitive phenotypes. Results: In a final sample of 8,564 individuals (mean age=9.9 years, 4,532 males) passing quality control, we identified 4,111 individuals carrying 5,760 autosomal CNVs. Our results revealed significant associations between specific CNVs and our phenotypes of interest, psychopathology and cognitive function. For instance, a duplication at 10q26.3 was associated with overall psychopathology, and somatic complaints in particular. Additionally, deletions at 1q12.1, along with duplications at 14q11.2 and 10q26.3, were linked to overall cognitive function, with particular contributions from fluid intelligence (14q11.2), working memory (10q26.3), and reading ability (14q11.2). Moreover, individuals carrying CNVs previously associated with neurodevelopmental disorders exhibited greater impairment in social functioning and cognitive performance across multiple domains, in particular working memory. Notably, a higher deletion CNV risk score was significantly correlated with increased overall psychopathology (especially in dimensions of social functioning, thought disorder, and attention) as well as cognitive impairment across various domains. Conclusions and Relevance: In summary, our findings shed light on the contributions of CNVs to interindividual variability in complex traits related to neurocognitive development and child psychopathology.
Genomic Balancing Act: deciphering DNA rearrangements in the complex chromosomal aberration involving 5p15.2, 2q31.1, and 18q21.32

Zain Dardas,Dana Marafi,Ruizhi Duan,Jawid M. Fatih,Omnia F. El-Rashidy,Christopher M. Grochowski,Claudia M. B. Carvalho,Shalini N. Jhangiani,Weimin Bi,Haowei Du,Richard A. Gibbs,Jennifer E. Posey,Daniel G. Calame,Maha S. Zaki,James R. Lupski

DOI: https://doi.org/10.1038/s41431-024-01680-1

2024-09-11

European Journal of Human Genetics

Abstract:Despite extensive research into the genetic underpinnings of neurodevelopmental disorders (NDD), many clinical cases remain unresolved. We studied a female proband with a NDD, mildly dysmorphic facial features, and brain stem hypoplasia on neuroimaging. Comprehensive genomic analyses revealed a terminal 5p loss and a terminal 18q gain in the proband while a diploid copy number for chromosomes 5 and 18 in both parents. Genomic investigations in the proband identified an unbalanced translocation t(5;18) with additional genetic material from chromosome 2 (2q31.3) inserted at the breakpoint, pointing to a complex chromosomal rearrangement (CCR) involving 5p15.2, 2q31.3, and 18q21.32. Breakpoint junction analyses enabled by long-read genome sequencing unveiled the presence of four distinct junctions in the father, who is a carrier of a balanced CCR. The proband inherited from the father both the abnormal chromosome 5 resulting in segmental aneusomies of chr5 (loss) and chr18 (gain) and a der(2) homologue. Evidences suggest a chromoplexy mechanism for this CCR derivation, involving double-strand breaks (DSBs) repaired by non-homologous end joining (NHEJ) or alternative end joining (alt-EJ). The complexity of the CCR and the segregation of homologues elucidate the genetic model for this family. This study demonstrates the importance of combining multiple genomic technologies to uncover genetic causes of complex neurodevelopmental syndromes and to better understand genetic disease mechanisms.

genetics & heredity,biochemistry & molecular biology
A common variant near TGFBR3 is associated with primary open angle glaucoma.

Zheng Li,R Rand Allingham,Masakazu Nakano,Liyun Jia,Yuhong Chen,Yoko Ikeda,Baskaran Mani,Li-Jia Chen,Changwon Kee,David F Garway-Heath,Sarangapani Sripriya,Nobuo Fuse,Khaled K Abu-Amero,Chukai Huang,Prasanthi Namburi,Kathryn Burdon,Shamira A Perera,Puya Gharahkhani,Ying Lin,Morio Ueno,Mineo Ozaki,Takanori Mizoguchi,Subbiah Ramasamy Krishnadas,Essam A Osman,Mei Chin Lee,Anita S Y Chan,Liza-Sharmini A Tajudin,Tan Do,Aurelien Goncalves,Pascal Reynier,Hong Zhang,Rupert Bourne,David Goh,David Broadway,Rahat Husain,Anil K Negi,Daniel H Su,Ching-Lin Ho,Augusto Azuara Blanco,Christopher K S Leung,Tina T Wong,Azhany Yakub,Yutao Liu,Monisha E Nongpiur,Jong Chul Han,Do Nhu Hon,Balekudaru Shantha,Bowen Zhao,Jinghong Sang,NiHong Zhang,Ryuichi Sato,Kengo Yoshii,Songhomita Panda-Jonas,Allison E Ashley Koch,Leon W Herndon,Sayoko E Moroi,Pratap Challa,Jia Nee Foo,Jin-Xin Bei,Yi-Xin Zeng,Cameron P Simmons,Tran Nguyen Bich Chau,Philomenadin Ferdinamarie Sharmila,Merwyn Chew,Blanche Lim,Pansy O S Tam,Elaine Chua,Xiao Yu Ng,Victor H K Yong,Yaan Fun Chong,Wee Yang Meah,Saravanan Vijayan,Sohn Seongsoo,Wang Xu,Yik Ying Teo,Jessica N Cooke Bailey,Jae H Kang,Jonathan L Haines,Ching Yu Cheng,Seang-Mei Saw,E-Shyong Tai,ICAARE-Glaucoma Consortium,NEIGHBORHOOD Consortium,Julia E Richards,Robert Ritch,Douglas E Gaasterland,Louis R Pasquale,Jianjun Liu,Jost B Jonas,Dan Milea,Ronnie George,Saleh A Al-Obeidan,Kazuhiko Mori,Stuart Macgregor,Alex W Hewitt,Christopher A Girkin,Mingzhi Zhang,Periasamy Sundaresan,Lingam Vijaya,David A Mackey,Tien Yin Wong,Jamie E Craig,Xinghuai Sun,Shigeru Kinoshita,Janey L Wiggs,Chiea-Chuen Khor,Zhenglin Yang,Chi Pui Pang,Ningli Wang,Michael A Hauser,Kei Tashiro,Tin Aung,Eranga N Vithana

DOI: https://doi.org/10.1093/hmg/ddv128

IF: 5.1214

2015-01-01

Human Molecular Genetics

Abstract:Primary open angle glaucoma (POAG), a major cause of blindness worldwide, is a complex disease with a significant genetic contribution. We performed Exome Array (Illumina) analysis on 3504 POAG cases and 9746 controls with replication of the most significant findings in 9173 POAG cases and 26 780 controls across 18 collections of Asian, African and European descent. Apart from confirming strong evidence of association at CDKN2B-AS1 (rs2157719 [G], odds ratio [OR] = 0.71, P = 2.81 × 10(-33)), we observed one SNP showing significant association to POAG (CDC7-TGFBR3 rs1192415, ORG-allele = 1.13, Pmeta = 1.60 × 10(-8)). This particular SNP has previously been shown to be strongly associated with optic disc area and vertical cup-to-disc ratio, which are regarded as glaucoma-related quantitative traits. Our study now extends this by directly implicating it in POAG disease pathogenesis.
Protein-altering variants at copy number-variable regions influence diverse human phenotypes

Margaux L. A. Hujoel,Robert E. Handsaker,Maxwell A. Sherman,Nolan Kamitaki,Alison R. Barton,Ronen E. Mukamel,Chikashi Terao,Steven A. McCarroll,Po-Ru Loh

DOI: https://doi.org/10.1038/s41588-024-01684-z

IF: 30.8

2024-03-28

Nature Genetics

Abstract:Copy number variants (CNVs) are among the largest genetic variants, yet CNVs have not been effectively ascertained in most genetic association studies. Here we ascertained protein-altering CNVs from UK Biobank whole-exome sequencing data ( n = 468,570) using haplotype-informed methods capable of detecting subexonic CNVs and variation within segmental duplications. Incorporating CNVs into analyses of rare variants predicted to cause gene loss of function (LOF) identified 100 associations of predicted LOF variants with 41 quantitative traits. A low-frequency partial deletion of RGL3 exon 6 conferred one of the strongest protective effects of gene LOF on hypertension risk (odds ratio = 0.86 (0.82–0.90)). Protein-coding variation in rapidly evolving gene families within segmental duplications—previously invisible to most analysis methods—generated some of the human genome's largest contributions to variation in type 2 diabetes risk, chronotype and blood cell traits. These results illustrate the potential for new genetic insights from genomic variation that has escaped large-scale analysis to date.

genetics & heredity
Novel variants identified in a three‑generation family with concomitant exotropia

Jiaxun Li,Yishi Ma,Wentao Zhou,Wenchao Lyu,Liming Wang,Song Mao,Jin Li,Xuefeng Shi

DOI: https://doi.org/10.3892/etm.2022.11624

2022-09-23

Abstract:Concomitant exotropia is a condition where there is a misalignment between both eyes, which is more prevalent in Asians than in Caucasians. It is an eye disease related to the neural development of binocular vision and eye movement control. Studies have indicated that genetic factors contribute to the development of concomitant exotropia; however, the underlying mutations have not been thoroughly investigated to date. In the present study, whole-exome sequencing was performed in a three-generation family with concomitant exotropia. In the proband and the proband's father, bioinformatics analyses identified a duplication of the genomic region spanning genes PCDHA1-7 and a heterozygous mutation c.3775G>A (p.A1259T) of the COL3A1 gene, which is located in the conserved COLFI domain and leads to decreased stability of the encoded protein product. Furthermore, a deletion of amino acid S165 in the gene NCOA7 was discovered in the family members, including the proband, the proband's mother and maternal grandfather. S165 was predicted to be a conserved phosphokinase site of CK1/VRK and CK1/CK1. The genes in which these variants reside are all involved in cortical neuronal development. The present study reveals novel variants of concomitant exotropia and suggests that aberrant cortical neuronal development may contribute to the origin of concomitant strabismus.
A systematic review and pooled analysis of penetrance estimates of copy number variants associated with neurodevelopment

Shuxiang Goh,Lavvina Thiyagarajan,Tracy Dudding-Byth,Pinese Mark,Edwin P Kirk

DOI: https://doi.org/10.1016/j.gim.2024.101227

2024-07-30

Abstract:Purpose: Many copy number variants (CNVs) are reported to cause a variety of neurodevelopmental disabilities including intellectual disability, developmental delay, autism and other phenotypes with incomplete penetrance, so not all individuals with a pathogenic CNV are affected. Penetrance estimates vary between studies. A systematic review was conducted to clarify CNV penetrance for 83 recurrent CNVs. Methods: A systematic review using PRISMA guidelines (PROSPERO #CRD42021253955) was conducted to identify penetrance estimates for CNVs associated with neurodevelopment. Pooled analysis was performed using forest plots. The Ottawa Risk of Bias Assessment facilitated evaluation. Results: Fifteen studies were reviewed in detail with nine affected cohorts pooled and compared against the gnomAD v4.0 CNV control cohort of 269,885 individuals. Several CNVs previously associated with non-statistically significant penetrance estimates now exhibit statistically significant differences, contributing to emerging evidence for their pathogenicity (15q24 duplication [A-D breakpoints], 15q24.2q24.5 deletion and duplication (FBXO22), 17q11.2 duplication (NF1), 17q21.31 duplication (KANSL1) and 22q11.2 distal duplication). Additionally, evidence is presented for the benign nature of some CNVs (15q11.2 duplication (NIPA1) and 2q13 proximal duplication (NPHP1)). Conclusion: This is a large-scale systematic review of CNVs associated with neurodevelopment. A synopsis analysing penetrance and pathogenicity is provided for each of the 83 recurrent CNVs.
A recurrent deletion mutation in OPA1 causes autosomal dominant optic atrophy in a Chinese family

Liping Zhang,Wei Shi,Liming Song,Xiao Zhang,Lulu Cheng,Yanfang Wang,Xianglian Ge,Wei Li,Wei Zhang,Qingjie Min,Zi-Bing Jin,Jia Qu,Feng Gu

DOI: https://doi.org/10.1038/srep06936

IF: 4.6

2014-01-01

Scientific Reports

Abstract:Autosomal dominant optic atrophy (ADOA) is the most frequent form of hereditary optic neuropathy and occurs due to the degeneration of the retinal ganglion cells. To identify the genetic defect in a family with putative ADOA, we performed capture next generation sequencing (CNGS) to screen known retinal disease genes. However, six exons failed to be sequenced by CNGS in optic atrophy 1 gene ( OPA1 ). Sequencing of those exons identified a 4 bp deletion mutation (c.2983-1_2985del) in OPA1 . Furthermore, we sequenced the transcripts of OPA1 from the patient skin fibroblasts and found there is six-nucleotide deletion (c.2984-c.2989, AGAAAG). Quantitative-PCR and Western blotting showed that OPA1 mRNA and its protein expression have no obvious difference between patient skin fibroblast and control. The analysis of protein structure by molecular modeling suggests that the mutation may change the structure of OPA1 by formation of an alpha helix protruding into an existing pocket. Taken together, we identified an OPA1 mutation in a family with ADOA by filling the missing CNGS data. We also showed that this mutation affects the structural intactness of OPA1. It provides molecular insights for clinical genetic diagnosis and treatment of optic atrophy.
Distinct Neurocognitive Profiles and Clinical Phenotypes Associated with Copy Number Variation at the 22q11.2 Locus

Kathleen P O'Hora,Leila Kushan-Wells,Gil D Hoftman,Maria Jalbrzikowski,Raquel C Gur,Ruben Gur,Carrie E Bearden

DOI: https://doi.org/10.1101/2023.05.12.23289905

2023-05-16

MedRxiv

Abstract:Rare genetic variants that confer large effects on neurodevelopment and behavioral phenotypes can reveal novel gene-brain-behavior relationships relevant to autism. Copy number variation at the 22q11.2 locus offer one compelling example, as both the 22q11.2 deletion (22qDel) and duplication (22qDup) confer increased likelihood of autism spectrum disorders (ASD) and cognitive deficits, but only 22qDel confers increased psychosis risk. Here, we used the Penn Computerized Neurocognitive Battery (Penn-CNB) to characterized neurocognitive profiles of 126 individuals: 55 22qDel carriers (MAge=19.2 years, 49.1% male), 30 22qDup carriers (MAge=17.3 years, 53.3 % male), and 41 typically developing (TD) subjects (MAge=17.3 years, 39.0 % male). We performed linear mixed models to assess group differences in overall neurocognitive profiles, domain scores, and individual test scores. We found all three groups exhibited distinct overall neurocognitive profiles. 22qDel and 22qDup carriers showed significant accuracy deficits across all domains relative to controls (Episodic Memory, Executive Function, Complex Cognition, Social Cognition, and Sensorimotor Speed), with 22qDel carriers exhibiting more severe accuracy deficits, particularly in Episodic Memory. However, 22qDup carriers generally showed greater slowing than 22qDel carriers. Notably, slower social cognition speed was uniquely associated with increased global psychopathology and poorer psychosocial functioning in 22qDup. Compared to TD, 22q11.2 CNV carriers failed to show age-associated improvements in multiple cognitive domains. Exploratory analyses revealed 22q11.2 CNV carriers with ASD exhibited differential neurocognitive profiles, based on 22q11.2 copy number. These results suggest that there are distinct neurocognitive profiles associated with either a loss or gain of genomic material at the 22q11.2 locus.
Genome-wide scans of myopia in Pennsylvania Amish families reveal significant linkage to 12q15, 8q21.3 and 5p15.33

Anthony M. Musolf,Claire L. Simpson,Theresa A. Alexander,Laura Portas,Federico Murgia,Elise B. Ciner,Dwight Stambolian,Joan E. Bailey-Wilson

DOI: https://doi.org/10.1007/s00439-019-01991-0

2019-03-02

Human Genetics

Abstract:Myopia is one of the most common ocular disorders in the world, yet the genetic etiology of the disease remains poorly understood. Specialized founder populations, such as the Pennsylvania Amish, provide the opportunity to utilize exclusive genomic architecture, like unique haplotypes, to better understand the genetic causes of myopia. We perform genetic linkage analysis on Pennsylvania Amish families that have a strong familial history of myopia to map any potential causal variants and genes for the disease. 293 individuals from 25 extended families were genotyped on the Illumina ExomePlus array and merged with previous microsatellite data. We coded myopia affection as a binary phenotype; myopia was defined as having a mean spherical equivalent (MSE) of less than or equal to − 1 D (diopters). Two-point and multipoint parametric linkage analyses were performed under an autosomal dominant model. When allowing for locus heterogeneity, we identified two novel genome-wide significantly linked variants at 12q15 (heterogeneity LOD, HLOD = 3.77) in PTPRB and at 8q21.3 (HLOD = 3.35) in CNGB3. We identified further three genome-wide significant variants within a single family. These three variants were located in exons of SLC6A18 at 5p15.33 (LODs ranged from 3.51 to 3.37). Multipoint analysis confirmed the significant signal at 5p15.33 with six genome-wide significant variants (LODs ranged from 3.6 to 3.3). Further suggestive evidence of linkage was observed in several other regions of the genome. All three novel linked regions contain strong candidate genes, especially CNGB3 on 8q21.3, which has been shown to affect photoreceptors and cause complete color blindness. Whole genome sequencing on these regions is planned to conclusively elucidate the causal variants.

genetics & heredity
Deletion upstream of MAB21L2 highlights the importance of evolutionarily conserved non-coding sequences for eye development

Fabiola Ceroni,Munevver B. Cicekdal,Richard Holt,Elena Sorokina,Nicolas Chassaing,Samuel Clokie,Thomas Naert,Lidiya V. Talbot,Sanaa Muheisen,Dorine A. Bax,Yesim Kesim,Emma C. Kivuva,Catherine Vincent-Delorme,Soeren S. Lienkamp,Julie Plaisancié,Elfride De Baere,Patrick Calvas,Kris Vleminckx,Elena V. Semina,Nicola K. Ragge

DOI: https://doi.org/10.1038/s41467-024-53553-2

IF: 16.6

2024-10-27

Nature Communications

Abstract:Anophthalmia, microphthalmia and coloboma (AMC) comprise a spectrum of developmental eye disorders, accounting for approximately 20% of childhood visual impairment. While non-coding regulatory sequences are increasingly recognised as contributing to disease burden, characterising their impact on gene function and phenotype remains challenging. Furthermore, little is known of the nature and extent of their contribution to AMC phenotypes. We report two families with variants in or near MAB21L2 , a gene where genetic variants are known to cause AMC in humans and animal models. The first proband, presenting with microphthalmia and coloboma, has a likely pathogenic missense variant (c.338 G > C; p.[Trp113Ser]), segregating within the family. The second individual, presenting with microphthalmia, carries an ~ 113.5 kb homozygous deletion 19.38 kb upstream of MAB21L2 . Modelling of the deletion results in transient small lens and coloboma as well as midbrain anomalies in zebrafish, and microphthalmia and coloboma in Xenopus tropicalis . Using conservation analysis, we identify 15 non-coding conserved elements (CEs) within the deleted region, while ChIP-seq data from mouse embryonic stem cells demonstrates that two of these (CE13 and 14) bind Otx2, a protein with an established role in eye development. Targeted disruption of CE14 in Xenopus tropicalis recapitulates an ocular coloboma phenotype, supporting its role in eye development. Together, our data provides insights into regulatory mechanisms underlying eye development and highlights the importance of non-coding sequences as a source of genetic diagnoses in AMC.

multidisciplinary sciences

Genetic underpinnings explored: OPA1 deletion and complex phenotypes on chromosome 3q29

A Novel OPA1 Mutation in a Chinese Family with Autosomal Dominant Optic Atrophy

Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.

Novel heterozygous OPA3 variant in a family with congenital cataracts, sensorineural hearing loss and neuropathy, without optic atrophy and comparison of pathogenic and population variants

A Large Family with Inherited Optic Disc Anomalies: a Correlation Between a New Genetic Locus and Complex Ocular Phenotypes

Looks Can Be Deceiving: Diagnostic Power of Exome Sequencing in Debunking 15q11.2 Copy Number Variations

Increasing the Yield in Targeted Next-Generation Sequencing by Implicating CNV Analysis, Non-Coding Exons and the Overall Variant Load: The Example of Retinal Dystrophies

Extremely rare CNVs contributing to Alzheimer disease risk: a case-control association analysis of exome sequencing data from 22,319 individuals

Structural Variant Disrupting the Expression of the Remote FOXC1 Gene in a Patient with Syndromic Complex Microphthalmia

A custom capture sequence approach for oculocutaneous albinism identifies structural variant alleles at the OCA2 locus

The copy number variant architecture of psychopathology and cognitive development in the ABCD study

Genomic Balancing Act: deciphering DNA rearrangements in the complex chromosomal aberration involving 5p15.2, 2q31.1, and 18q21.32

A common variant near TGFBR3 is associated with primary open angle glaucoma.

Protein-altering variants at copy number-variable regions influence diverse human phenotypes

Novel variants identified in a three‑generation family with concomitant exotropia

A systematic review and pooled analysis of penetrance estimates of copy number variants associated with neurodevelopment

A recurrent deletion mutation in OPA1 causes autosomal dominant optic atrophy in a Chinese family

Distinct Neurocognitive Profiles and Clinical Phenotypes Associated with Copy Number Variation at the 22q11.2 Locus

Genome-wide scans of myopia in Pennsylvania Amish families reveal significant linkage to 12q15, 8q21.3 and 5p15.33

Deletion upstream of MAB21L2 highlights the importance of evolutionarily conserved non-coding sequences for eye development